Cargando…
Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells
Multiple myeloma is the second most prevalent type of blood cancer, representing approximately 1% of all cancers and 2% of all cancer deaths. There is therefore a strong need to identify critical targets in multiple myeloma neoplasia and progression. Cancerous inhibitor of PP2A (CIP2A) is a human on...
Autores principales: | Yang, Xi, Zhang, Yaping, Liu, Hong, Lin, Zenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837246/ https://www.ncbi.nlm.nih.gov/pubmed/27144172 http://dx.doi.org/10.1155/2016/6864135 |
Ejemplares similares
-
Silencing of augmenter of liver regeneration inhibited cell proliferation and triggered apoptosis in U266 human multiple myeloma cells
por: Zeng, H.Q., et al.
Publicado: (2017) -
Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p
por: Yang, Xi, et al.
Publicado: (2020) -
PB2082: BONE MORPHOGENIC PROTEIN-6 PROMOTES THE PROLIFERATION AND INHIBITS APOPTOSIS IN MULTIPLE MYELOMA
por: Fu, Jiaqi, et al.
Publicado: (2023) -
Multiple Myeloma Side Population Cells Promote Dexamethasone Resistance of Main Population Cells through Exosome Metastasis of LncRNA SNHG16
por: Yang, Xi, et al.
Publicado: (2023) -
Rhotekin 2 silencing inhibits proliferation and induces apoptosis in human osteosarcoma cells
por: Wang, Xiong, et al.
Publicado: (2018)